AzTrials
AzTrials

Brain Injuries, TraumaticLAPDYANCT05942638

Longitudinal Assessment of Post-concussion Driving in Young Adults

An observational study of Brain Injuries, Traumatic and Concussion, Brain, run by University of Georgia at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Upwards of 3.8 million concussions occur annually in the United States. Driving is a highly complicated activity that requires visual, motor, and cognitive skills, which are commonly impaired after concussion. Yet, the time course of post-concussion driving impairment has not been characterized. Read more about this study

Who is it for?
Ages 18 years and older
How many people
1,000 participants
Where
1 siteUnited States
Study dates
29 Aug 2023to Jun 2028
How long will I take part?
5 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Athletes rostered in an organized sport at the collegiate level

Who may be able to join

  • 18 years old or older
  • Possesses a valid driver's license
  • 1 year or more of driving experience
  • Normal or corrected-to-normal vision
  • Rostered on an organized athletic team at the college level
  • (Concussion Group Only) Diagnosed with concussion by a physician and meet inclusion criteria above.

Who cannot join

  • Four or more previous concussions
  • A concussion within the past 6 months
  • History of any major neurological disorders or injuries
  • Current use of any medications that evoke drowsiness (prescription or over the counter)
  • Current orthopedic condition that interferes with driving (e.g. a walking boot, shoulder immobilizer)
  • Heavy use of alcohol (binge drinking 5+ days in the past 30 days)
  • Any illegal drug use (any illegal substance use)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Ramsey Student Center

    Athens, Georgia, 30602

Other trials in United States

About this study

Upwards of 3.8 million concussions occur annually in the United States. Driving is a highly complicated activity that requires visual, motor, and cognitive skills, which are commonly impaired after concussion. Yet, the time course of post-concussion driving impairment has not been characterized. There is a critical need to 1) determine when concussed individuals should return to driving and 2) identify the key concussion assessment predictors of readiness to return to driving. In the absence of formal recommendations, impaired concussed drivers are at risk to themselves and others on the road.

The first specific aim is to compare simulated driving between concussed individuals and non-concussed yoked matched controls across five longitudinal timepoints (pre-injury baseline, day 2, day 4, asymptomatic, and unrestricted medical clearance) and daily naturalistic driving from day 2 to day 9.

Read more

Driving recommendations must be appropriate and necessitated by concussion impairments, since excessively strict recommendations wrongfully strip concussed patients of their independence and may dissuade individuals from seeking medical care. The second specific aim is to identify widely used concussion assessment outcomes that predict simulated driving performance among concussed individuals throughout concussion recovery.

To address these aims, 100 concussed and 100 yoked matched control young adult college athletes will complete a simulated driving assessment and a robust concussion assessment battery at pre-injury baseline, day 2, day 4, asymptomatic, and unrestricted medical clearance. Naturalistic driving (measured with in-car global positioning systems) will be captured from day 2 to day 9 (7 days total).

This study will determine the acute and subacute time course of post-concussion driving impairment and determine key predictors of post-concussion driving performance. Results from this innovative approach will have a broad and positive impact that will improve the safety of both concussed individuals and the general population, guide the practices of health professionals, inform the future work of researchers, and substantiate the work of policy-makers by providing evidence-based recommendations for managing post-concussion driving.

Medical subject headings
Brain Injuries, Traumatic, Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05942638
Study groupRoleWhat they receive
Concussion GroupNot described
Control GroupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Centerline Crossings (count)

    Count of centerline crossings during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline

  2. Centerline Crossings (count)

    Count of centerline crossings during a custom STISIM3 driving simulation scenario

    Measured: Day 2

  3. Centerline Crossings (count)

    Count of centerline crossings during a custom STISIM3 driving simulation scenario

    Measured: Day 4

  4. Centerline Crossings (count)

    Count of centerline crossings during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  5. Centerline Crossings (count)

    Count of centerline crossings during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  6. Road edge excursions (count)

    Count of road edge excursions during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline

  7. Road edge excursions (count)

    Count of road edge excursions during a custom STISIM3 driving simulation scenario

    Measured: Day 2

  8. Road edge excursions (count)

    Count of road edge excursions during a custom STISIM3 driving simulation scenario

    Measured: Day 4

  9. Road edge excursions (count)

    Count of road edge excursions during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  10. Road edge excursions (count)

    Count of road edge excursions during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  11. Total Collisions (count)

    Count of collisions during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline

  12. Total Collisions (count)

    Count of collisions during a custom STISIM3 driving simulation scenario

    Measured: Day 2

  13. Total Collisions (count)

    Count of collisions during a custom STISIM3 driving simulation scenario

    Measured: Day 4

  14. Total Collisions (count)

    Count of collisions during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  15. Total Collisions (count)

    Count of collisions during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  16. Standard Deviation of Lane Position (feet)

    Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline

  17. Standard Deviation of Lane Position (feet)

    Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Day 2

  18. Standard Deviation of Lane Position (feet)

    Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Day 4

  19. Standard Deviation of Lane Position (feet)

    Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  20. Standard Deviation of Lane Position (feet)

    Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  21. Standard Deviation of speed (miles per hour)

    Variability of driving speed during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline

  22. Standard Deviation of speed (miles per hour)

    Variability of driving speed during a custom STISIM3 driving simulation scenario

    Measured: Day 2

  23. Standard Deviation of speed (miles per hour)

    Variability of driving speed during a custom STISIM3 driving simulation scenario

    Measured: Day 4

  24. Standard Deviation of speed (miles per hour)

    Variability of driving speed during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  25. Standard Deviation of speed (miles per hour)

    Variability of driving speed during a custom STISIM3 driving simulation scenario

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  26. Number of drives per day (count)

    Total number of drives per day captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  27. Distance travelled per day (miles)

    Total distance driven per day captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  28. Drive time per day (minutes)

    Total drive time per day captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  29. Total symptom severity score

    Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    Measured: Day 2

  30. Total symptom severity score

    Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  31. Total symptom severity score

    Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  32. Verbal Memory

    Verbal memory domain score from CNS Vital Signs

    Measured: Day 2

  33. Verbal Memory

    Verbal memory domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  34. Verbal Memory

    Verbal memory domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  35. Visual Memory

    Visual memory domain score from CNS Vital Signs

    Measured: Day 2

  36. Visual Memory

    Visual memory domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  37. Visual Memory

    Visual memory domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  38. Psychomotor Speed

    Psychomotor speed domain score from CNS Vital Signs

    Measured: Day 2

  39. Psychomotor Speed

    Psychomotor speed domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  40. Psychomotor Speed

    Psychomotor speed domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  41. Reaction Time

    Reaction time domain score from CNS Vital Signs

    Measured: Day 2

  42. Reaction Time

    Reaction time domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  43. Reaction Time

    Reaction time domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  44. Complex attention

    Complex attention domain score from CNS Vital Signs

    Measured: Day 2

  45. Complex attention

    Complex attention domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  46. Complex attention

    Complex attention domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  47. Cognitive Flexibility

    Cognitive flexibility domain score from CNS Vital Signs

    Measured: Day 2

  48. Cognitive Flexibility

    Cognitive flexibility domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  49. Cognitive Flexibility

    Cognitive flexibility domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  50. Processing Speed

    Processing speed domain score from CNS Vital Signs

    Measured: Day 2

  51. Processing Speed

    Processing speed domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  52. Processing Speed

    Processing speed domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  53. Executive function

    Executive functions domain score from CNS Vital Signs

    Measured: Day 2

  54. Executive function

    Executive functions domain score from CNS Vital Signs

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  55. Executive function

    Executive functions domain score from CNS Vital Signs

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  56. Balance Error Scoring System Total Error Score (count)

    Number of errors committed during the Balance Error Scoring System

    Measured: Day 2

  57. Balance Error Scoring System Total Error Score (count)

    Number of errors committed during the Balance Error Scoring System

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  58. Balance Error Scoring System Total Error Score (count)

    Number of errors committed during the Balance Error Scoring System

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  59. Tandem Gait Time (seconds)

    Seconds to complete the tandem gait task

    Measured: Day 2

  60. Tandem Gait Time (seconds)

    Seconds to complete the tandem gait task

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  61. Tandem Gait Time (seconds)

    Seconds to complete the tandem gait task

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  62. Smooth Pursuit Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  63. Smooth Pursuit Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  64. Smooth Pursuit Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  65. Horizontal Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  66. Horizontal Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  67. Horizontal Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  68. Vertical Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  69. Vertical Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  70. Vertical Saccades Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  71. Convergence Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  72. Convergence Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  73. Convergence Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  74. Horizontal VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  75. Horizontal VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  76. Horizontal VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  77. Vertical VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  78. Vertical VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  79. Vertical VOR Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

  80. Visual Motion Sensitivity Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Day 2

  81. Visual Motion Sensitivity Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)

  82. Visual Motion Sensitivity Symptom Rating

    Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Measured: Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)

Secondary outcomes (15)
  1. Pedestrian Collisions (count)

    Count of pedestrian collisions during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  2. Speed exceedances (count)

    Count of speed exceedances during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  3. Percent time over speed limit (%)

    Percent time over speed limit during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  4. Percent time out of lane (%)

    Percent time out of lane during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  5. Lateral lane position (feet)

    Lateral lane position during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  6. Speed (miles per hour)

    Driving speed during a custom STISIM3 driving simulation scenario

    Measured: Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  7. Number of speeding events (count)

    Number of speeding events captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  8. Hard braking events (count)

    Hard braking events captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  9. Hard acceleration events (count)

    Hard acceleration events captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  10. Hard cornering events (count)

    Hard cornering events captured as a naturalistic driving outcomes

    Measured: Up to 9 days post-injury

  11. UFOV Processing Speed (ms)

    Processing Speed task performance during Useful Field of View Test

    Measured: Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  12. UFOV Divided Attention (ms)

    Divided attention task performance during Useful Field of View Test

    Measured: Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  13. UFOV Selective Attention (ms)

    Selective attention task performance during Useful Field of View Test

    Measured: Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  14. Rey Osterrieth Copy Score (count)

    Number of correct items when drawing figure during a Rey Osterrieth copy trial

    Measured: Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

  15. Rey Osterrieth Copy Time (sec)

    Time to draw a figure during a Rey Osterrieth copy trial

    Measured: Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2023
  2. Study start29 Aug 2023
  3. Primary completionJun 2028 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
Target duration
5 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT05942638
Sponsor's protocol ID
PROJECT00007249
Acronym
LAPDYA
Status last verified
Dec 2023
First submitted
28 Apr 2023
Last updated
13 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injuries, Traumatic and Concussion, Brain, run by University of Georgia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 13 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Centerline Crossings (count) (time frame: Pre-injury baseline). The study lists 82 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in